نتائج البحث

Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation.

• Authors : Rudzik KN; Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.; Schonder KS

Subjects: Liver Transplantation* ; Everolimus*/Everolimus*/Everolimus*/therapeutic use ; Everolimus*/Everolimus*/Everolimus*/administration & dosage

• Source: Clinical transplantation [Clin Transplant] 2024 Jul; Vol. 38 (7), pp. e15402.Publisher: Munksgaard Country of Publication: Denmark NLM ID: 8710240 Publication Model: Print Cited Medium: Internet ISSN: 1399-0012

تفاصيل العنوان

Safety and efficacy of everolimus initiation from the first month after liver transplantation: A systematic review and meta-analysis.

• Authors : Cholongitas E; First Department of Internal Medicine, Laiko General Hospital, Medical School of National and Kapodistrian University of Athens, Athens, Greece.; Burra P

Subjects: Liver Transplantation*/Liver Transplantation*/Liver Transplantation*/adverse effects ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery

• Source: Clinical transplantation [Clin Transplant] 2023 May; Vol. 37 (5), pp. e14957. Date of Electronic Publication: 2023 Mar 07.Publisher: Munksgaard Country of Publication: Denmark NLM ID: 8710240 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-0012

تفاصيل العنوان

Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study.

• Authors : Saliba F; AP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, INSERM Unit 1193, Université Paris Saclay, Villejuif, France.; Duvoux C

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/etiology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/etiology ; Liver Transplantation*/Liver Transplantation*/Liver Transplantation*/adverse effects

• Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Nov; Vol. 42 (11), pp. 2513-2523. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics.

• Authors : Itohara K; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.; Yano I

Subjects: Liver Transplantation*/Liver Transplantation*/Liver Transplantation*/adverse effects ; Pediatrics*; Adult

• Source: Clinical and translational science [Clin Transl Sci] 2022 Nov; Vol. 15 (11), pp. 2652-2662. Date of Electronic Publication: 2022 Sep 14.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Exposure-response modeling for extrapolation from adult to pediatric patients who differ with respect to prognostic factors: Application to everolimus.

• Authors : Dumortier T; Pharmacometrics, Novartis Pharma AG, Basel, Switzerland.; Heimann G

Subjects: Everolimus*/Everolimus*/Everolimus*/administration & dosage ; Everolimus*/Everolimus*/Everolimus*/pharmacokinetics ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/administration & dosage

• Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2021 Jun; Vol. 10 (6), pp. 589-598. Date of Electronic Publication: 2021 May 11.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Everolimus-associated focal segmental glomerulosclerosis in a liver transplant recipient.

• Authors : Manabe S; Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.; Ino A

Subjects: Liver Transplantation*; Everolimus/Everolimus/Everolimus/*adverse effects ; Glomerulosclerosis, Focal Segmental/Glomerulosclerosis, Focal Segmental/Glomerulosclerosis, Focal Segmental/*chemically induced

• Source: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2021 Apr; Vol. 26 (4), pp. 371-372. Date of Electronic Publication: 2020 Dec 09.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Pregnancy in a liver transplant patient treated with everolimus and tacrolimus.

• Authors : Ciortea R; Iuliu Hatieganu University of Medicine and Pharmacy, Cluj- Napoca; 2 nd Obstetrics and Gynecology Department, County Hospital, Cluj-Napoca, Romania. . .

Subjects: Liver Transplantation* ; Tacrolimus*/Tacrolimus*/Tacrolimus*/adverse effects; Humans

• Source: Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2020 Dec 13; Vol. 29 (4), pp. 685-686. Date of Electronic Publication: 2020 Dec 13.Publisher:

تفاصيل العنوان

Insuficiencia suprarrenal por everolimus: a propósito de un caso clínico.

• Authors : Hernández Navas, Jorge Andrés¹ ; Therán León, Juan Sebastián¹; Dulcey Sarmiento, Luis Andrés²

• Source: Revista Horizonte Médico. ene-mar2025, Vol. 25 Issue 1, p124-127. 4p.

تفاصيل العنوان

Efficacy and safety of everolimus treatment on liver transplant recipients: A meta-analysis.

• Authors : Guan TW; Institute of Microbiology, Xihua University, Chengdu, China.; Lin YJ

Subjects: Graft Survival* ; Liver Transplantation* ; Mortality*

• Source: European journal of clinical investigation [Eur J Clin Invest] 2019 Dec; Vol. 49 (12), pp. e13179. Date of Electronic Publication: 2019 Nov 19.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

تفاصيل العنوان

MEASLES-MUMPS-RUBELLA VACCINATION IN A PAEDIATRIC TRANSPLANT PATIENT USING EVEROLIMUS.

• Authors : KAÇIR, Aybüke¹; BÜKE, Övgü¹ ; KARABAYIR, Nalan¹

• Source: Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 2025, Vol. 88 Issue 1, p80-82. 3p.

تفاصيل العنوان